PL2167498T3 - Związki i kompozycje jako inhibitory ITPKB - Google Patents

Związki i kompozycje jako inhibitory ITPKB

Info

Publication number: PL2167498T3
Authority: PL; Poland
Prior art keywords: compounds; compositions; itpkb; inhibitors; itpkb inhibitors
Prior art date: 2007-06-15

Application number

PL08770796T

Other languages

English (en)

Inventor

Badry Bursulaya

Dai Cheng

Jiqing Jiang

Donald S Karanewsky

Yi Liu

Shifeng Pan

Yongqin Wan

Xia Wang

Yun Feng Xie

Yang Yang

Original Assignee

Irm Llc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-06-15

Filing date

2008-06-12

Publication date

2011-03-31

2008-06-12 Application filed by Irm Llc filed Critical Irm Llc

2011-03-31 Publication of PL2167498T3 publication Critical patent/PL2167498T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Veterinary Medicine (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Pulmonology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Hematology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Pain & Pain Management (AREA)
Otolaryngology (AREA)
Transplantation (AREA)
Physical Education & Sports Medicine (AREA)
Gastroenterology & Hepatology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Hydrogenated Pyridines (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)

PL08770796T 2007-06-15 2008-06-12 Związki i kompozycje jako inhibitory ITPKB PL2167498T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US94435407P	2007-06-15	2007-06-15
PCT/US2008/066664 WO2008157210A1 (en)	2007-06-15	2008-06-12	Compounds and compositions as itpkb inhibitors
EP08770796A EP2167498B1 (en)	2007-06-15	2008-06-12	Compounds and compositions as itpkb inhibitors

Publications (1)

Publication Number	Publication Date
PL2167498T3 true PL2167498T3 (pl)	2011-03-31

Family

ID=39673403

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL08770796T PL2167498T3 (pl)	2007-06-15	2008-06-12	Związki i kompozycje jako inhibitory ITPKB

Country Status (16)

Country	Link
US (2)	US8178526B2 (pl)
EP (1)	EP2167498B1 (pl)
JP (1)	JP2010529993A (pl)
KR (1)	KR20100020997A (pl)
CN (1)	CN101743243A (pl)
AT (1)	ATE481400T1 (pl)
AU (1)	AU2008266185B2 (pl)
BR (1)	BRPI0813929A2 (pl)
CA (1)	CA2688487A1 (pl)
DE (1)	DE602008002600D1 (pl)
EA (1)	EA200901656A1 (pl)
ES (1)	ES2351545T3 (pl)
MX (1)	MX2009013215A (pl)
PL (1)	PL2167498T3 (pl)
PT (1)	PT2167498E (pl)
WO (1)	WO2008157210A1 (pl)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2720490A1 (en) *	2008-04-04	2009-10-08	Irm Llc	Compounds and compositions as itpkb inhibitors
CN108689876B (zh) *	2018-06-28	2020-11-27	苏州东南药业股份有限公司	一种8-(2-羟基苯甲酰胺基)辛酸钠的制备方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2692575B1 (fr) *	1992-06-23	1995-06-30	Sanofi Elf	Nouveaux derives du pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
NZ256620A (en)	1992-12-17	1996-05-28	Pfizer	Pyrazole derivatives; compounds and pharmaceutical compositions containing them; intermediate compounds
DE69615376T2 (de)	1995-07-13	2002-09-05	Knoll Gmbh	Piperazin-derivate als heilmittel
US6727264B1 (en) *	2001-07-05	2004-04-27	Synaptic Pharmaceutical Corporation	Substituted anilinic piperidines as MCH selective antagonists
GB0228417D0 (en)	2002-12-05	2003-01-08	Cancer Rec Tech Ltd	Pyrazole compounds
US7595148B2 (en)	2003-01-25	2009-09-29	Irm Llc	Methods and compositions for modulating T lymphocytes
MXPA05012460A (es)	2003-05-19	2006-05-25	Irm Llc	Compuestos y composiciones inmunosupresoras.
WO2005019182A1 (en)	2003-08-20	2005-03-03	Bayer Healthcare Ag	Pyrazolylmethylbenzamide derivatives as p2xt-receptor antagonists
US7569593B2 (en) *	2003-10-02	2009-08-04	Irm Llc	Compounds and compositions as protein kinase inhibitors
BRPI0608513A2 (pt) *	2005-03-15	2010-01-05	Irm Llc	compostos e composições como inibidores da proteìna quinase
TW200817375A (en)	2006-07-21	2008-04-16	Irm Llc	Compounds and compositions as ITPKB inhibitors

2008
- 2008-06-12 PL PL08770796T patent/PL2167498T3/pl unknown
- 2008-06-12 CN CN200880020327A patent/CN101743243A/zh active Pending
- 2008-06-12 WO PCT/US2008/066664 patent/WO2008157210A1/en active Application Filing
- 2008-06-12 DE DE602008002600T patent/DE602008002600D1/de active Active
- 2008-06-12 AU AU2008266185A patent/AU2008266185B2/en not_active Ceased
- 2008-06-12 ES ES08770796T patent/ES2351545T3/es active Active
- 2008-06-12 AT AT08770796T patent/ATE481400T1/de active
- 2008-06-12 EA EA200901656A patent/EA200901656A1/ru unknown
- 2008-06-12 CA CA002688487A patent/CA2688487A1/en not_active Abandoned
- 2008-06-12 PT PT08770796T patent/PT2167498E/pt unknown
- 2008-06-12 JP JP2010512344A patent/JP2010529993A/ja active Pending
- 2008-06-12 EP EP08770796A patent/EP2167498B1/en not_active Not-in-force
- 2008-06-12 MX MX2009013215A patent/MX2009013215A/es active IP Right Grant
- 2008-06-12 US US12/664,651 patent/US8178526B2/en not_active Expired - Fee Related
- 2008-06-12 BR BRPI0813929A patent/BRPI0813929A2/pt not_active IP Right Cessation
- 2008-06-12 KR KR1020107000836A patent/KR20100020997A/ko active IP Right Grant
2012
- 2012-04-12 US US13/445,644 patent/US20120202782A1/en not_active Abandoned

Also Published As

Publication number	Publication date
US20120202782A1 (en)	2012-08-09
WO2008157210A1 (en)	2008-12-24
JP2010529993A (ja)	2010-09-02
EP2167498A1 (en)	2010-03-31
CN101743243A (zh)	2010-06-16
MX2009013215A (es)	2010-01-25
US20100184748A1 (en)	2010-07-22
CA2688487A1 (en)	2008-12-24
US8178526B2 (en)	2012-05-15
EA200901656A1 (ru)	2010-06-30
AU2008266185B2 (en)	2011-12-08
AU2008266185A1 (en)	2008-12-24
ATE481400T1 (de)	2010-10-15
PT2167498E (pt)	2010-11-29
KR20100020997A (ko)	2010-02-23
BRPI0813929A2 (pt)	2017-05-09
ES2351545T3 (es)	2011-02-07
DE602008002600D1 (de)	2010-10-28
EP2167498B1 (en)	2010-09-15

Publication	Publication Date	Title
WO2008011611A3 (en)	2008-05-02	Compounds and compositions as itpkb inhibitors
TN2012000081A1 (en)	2013-09-19	Compounds and compositions as protein kinase inhibitors
MX2010010877A (es)	2010-10-26	Compuestos y composiciones como inhibidores de itpkb.
MX2009004716A (es)	2009-07-17	Compuestos y composiciones en la forma de inhibidores de quinasa de proteina.
MX2009007944A (es)	2009-08-07	Compuestos y composiciones de purina como inhibidores de quinasa para el tratamiento de enfermedades relacionadas con plasmodium.
TNSN08373A1 (en)	2009-12-29	Azolopyrimidines as inhibitors of cannabinoid 1 activity
MX2009006339A (es)	2009-08-21	Compuestos y composiciones como inhibidores de actividad de receptor 1 de cannabinoide.
MX2012002366A (es)	2012-03-29	Agonistas novedosos de receptores beta 3 andrenergicos derivados de pirrolidina.
HK1136283A1 (en)	2010-06-25	Compounds for the prevention and treatment of cardiovascular diseases
TN2010000122A1 (en)	2011-09-26	Compounds and compositions as modulators of gpr119 activity
MX2009009491A (es)	2009-09-16	Compuestos y composiciones como moduladores de la actividad del gpr119.
GEP20135724B (en)	2013-01-10	Aminotetrahydropyrans as dipeptidyl peptidase-iv inhibitors for treatment or prevention of diabetes
MX2009011951A (es)	2009-12-11	Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr.
MX2010009752A (es)	2010-09-30	Compuestos de oxadiazoantraceno para el tratamiento de diabetes.
DE602006016449D1 (pl)	2010-10-07
MX2009010207A (es)	2009-10-19	Peptidos de hidrazido como inhibidores de proteasa ns3 de virus de hepatitis c.
UA103930C2 (ru)	2013-12-10	Соединения и композиция для лечения паразитарных болезней
MX2008002166A (es)	2008-04-22	Compuestos y composiciones como mimeticos de trombopoietina (tpo).
TNSN08370A1 (en)	2009-12-29	Tetrahydropyridothienopyrimidine compounds and methods of use thereof
MX2009011952A (es)	2009-12-11	Compuestos y composiciones como inhibidores de cinasa c-kit y pdgfr.
AU2011279845A8 (en)	2014-11-20	Novel pyrrolidine derived beta 3 adrenergic receptor agonists
WO2009097973A3 (de)	2009-10-01	Imidazopyridazine als par1-inhibitoren, ihre herstellung und verwendung als arzneimittel
PL2167498T3 (pl)	2011-03-31	Związki i kompozycje jako inhibitory ITPKB
MY152040A (en)	2014-08-15	Triazolopyridazines as par1 inhibitors, production thereof, and use as medicaments
WO2009151495A3 (en)	2010-08-26	Oxazole compounds, compositions and methods of use